{"document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals resolves default on some of its $30 billion debt by filing its long-delayed United States financial report for 2015; accounting problems at company linger.", "multimedia": [], "headline": {"print_headline": "Valeant Files U.S. Report as Accounting Issues Linger", "main": "Valeant Pharmaceuticals Files Overdue U.S. 2015 Financial Report"}, "print_page": "6", "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Company Reports", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Addyi (Drug)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Philidor Rx Services LLC", "is_major": "N", "rank": "5", "name": "organizations"}], "snippet": "The Canadian drug maker is dealing with three federal inquiries into its accounting and business practices, and a huge plunge in its stock price.", "source": "The New York Times", "lead_paragraph": "The Canadian drug maker is dealing with three federal inquiries into its accounting and business practices, and a huge plunge in its stock price.", "word_count": "446", "pub_date": "2016-04-30T04:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/04/30/business/valeant-pharmaceuticals-files-overdue-us-2015-financial-report.html", "_id": "5723f8f938f0d83e7bbb56c8"}